|
|
|
|
pmid:
|
Bisogno T et al. |
Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10079192
|
Self DW |
Anandamide: a candidate neurotransmitter heads for the big leagues. |
1999 |
Nat. Neurosci. |
pmid:10204533
|
Giuffrida A et al. |
Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. |
1999 |
Nat. Neurosci. |
pmid:10204543
|
Bisogno T et al. |
Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin. |
1999 |
J. Neurochem. |
pmid:10217292
|
Piomelli D et al. |
Structural determinants for recognition and translocation by the anandamide transporter. |
1999 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:10318965
|
Sugiura T et al. |
[2-Arachidonoylglycerol: an endogenous cannabinoid receptor agonist]. |
1999 |
Tanpakushitsu Kakusan Koso |
pmid:10396990
|
Di Marzo V et al. |
Metabolism of anandamide and 2-arachidonoylglycerol: an historical overview and some recent developments. |
1999 |
Lipids |
pmid:10419192
|
Di Marzo V et al. |
Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. |
1999 |
Eur. J. Biochem. |
pmid:10447696
|
Martin BR et al. |
Discovery and characterization of endogenous cannabinoids. |
1999 |
Life Sci. |
pmid:10462059
|
Di Marzo V |
Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators. |
1999 |
Life Sci. |
pmid:10462065
|
Bisogno T et al. |
Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina. |
1999 |
Arch. Biochem. Biophys. |
pmid:10577359
|
Melck D et al. |
Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. |
2000 |
Endocrinology |
pmid:10614630
|
Sugiura T et al. |
Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. |
2000 |
J. Biol. Chem. |
pmid:10617657
|
Sinor AD et al. |
Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. |
2000 |
Neurosci. Lett. |
pmid:10653017
|
Schmid PC et al. |
A sensitive endocannabinoid assay. The simultaneous analysis of N-acylethanolamines and 2-monoacylglycerols. |
2000 |
Chem. Phys. Lipids |
pmid:10669310
|
Járai Z et al. |
Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice. |
2000 |
Hypertension |
pmid:10679517
|
Ameri A and Simmet T |
Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices. |
2000 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:10731038
|
González S et al. |
Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:10733937
|
Gonsiorek W et al. |
Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. |
2000 |
Mol. Pharmacol. |
pmid:10779390
|
Hillard CJ |
Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol. |
2000 |
Prostaglandins Other Lipid Mediat. |
pmid:10785538
|
Di Marzo V et al. |
Cannabimimetic fatty acid derivatives in cancer and inflammation. |
2000 |
Prostaglandins Other Lipid Mediat. |
pmid:10785541
|
Kunos G et al. |
Cardiovascular effects of endocannabinoids--the plot thickens. |
2000 |
Prostaglandins Other Lipid Mediat. |
pmid:10785543
|
Sugiura T et al. |
Generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in picrotoxinin-administered rat brain. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:10814517
|
Beltramo M and Piomelli D |
Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. |
2000 |
Neuroreport |
pmid:10817598
|
Sugiura T and Waku K |
2-arachidonoylglycerol: a possible multifunctional lipid mediator in the nervous and immune systems. |
2000 |
Ann. N. Y. Acad. Sci. |
pmid:10818479
|
Jarrahian A et al. |
Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter. |
2000 |
J. Neurochem. |
pmid:10820223
|
Hillard CJ |
Endocannabinoids and vascular function. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10871291
|
Di Marzo V et al. |
Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. |
2000 |
FASEB J. |
pmid:10877836
|
Suhara Y et al. |
Synthesis and biological activities of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, and its metabolically stable ether-linked analogues. |
2000 |
Chem. Pharm. Bull. |
pmid:10923815
|
Kozak KR et al. |
Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. |
2000 |
J. Biol. Chem. |
pmid:10931854
|
Martin BR et al. |
Cannabinoid properties of methylfluorophosphonate analogs. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10945879
|
Chen Y et al. |
Human brain capillary endothelium: 2-arachidonoglycerol (endocannabinoid) interacts with endothelin-1. |
2000 |
Circ. Res. |
pmid:10948067
|
Stefano GB et al. |
2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1. |
2000 |
Pharmacol. Res. |
pmid:10987990
|
Szallasi A and Di Marzo V |
New perspectives on enigmatic vanilloid receptors. |
2000 |
Trends Neurosci. |
pmid:11006466
|
Gallily R et al. |
2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice. |
2000 |
Eur. J. Pharmacol. |
pmid:11011050
|
Di Marzo V et al. |
Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide. |
2000 |
Eur. J. Pharmacol. |
pmid:11040343
|
Di Marzo V et al. |
Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. |
2000 |
J. Neurochem. |
pmid:11080195
|
Rhee MH et al. |
Functional role of tryptophan residues in the fourth transmembrane domain of the CB(2) cannabinoid receptor. |
2000 |
J. Neurochem. |
pmid:11080201
|
Pryor SR |
Is platelet release of 2-arachidonoyl-glycerol a mediator of cognitive deficits? An endocannabinoid theory of schizophrenia and arousal. |
2000 |
Med. Hypotheses |
pmid:11090297
|
Maccarrone M et al. |
Anandamide and 2-arachidonoylglycerol inhibit fatty acid amide hydrolase by activating the lipoxygenase pathway of the arachidonate cascade. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:11095952
|
Calignano A et al. |
A role for the endogenous cannabinoid system in the peripheral control of pain initiation. |
2000 |
Prog. Brain Res. |
pmid:11098711
|
Howlett AC and Mukhopadhyay S |
Cellular signal transduction by anandamide and 2-arachidonoylglycerol. |
2000 |
Chem. Phys. Lipids |
pmid:11106782
|
Sugiura T and Waku K |
2-Arachidonoylglycerol and the cannabinoid receptors. |
2000 |
Chem. Phys. Lipids |
pmid:11106784
|
Basavarajappa BS et al. |
Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons. |
2000 |
Biochim. Biophys. Acta |
pmid:11113634
|
Sugiura T et al. |
Rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain after decapitation. |
2001 |
Neurosci. Lett. |
pmid:11137756
|
Baker D et al. |
Endocannabinoids control spasticity in a multiple sclerosis model. |
2001 |
FASEB J. |
pmid:11156943
|
MacCarrone M et al. |
Human platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptor. |
2001 |
Eur. J. Biochem. |
pmid:11168423
|
Moody JS et al. |
Selective oxygenation of the endocannabinoid 2-arachidonylglycerol by leukocyte-type 12-lipoxygenase. |
2001 |
Biochemistry |
pmid:11170406
|
Huang SM et al. |
Liquid chromatographic-mass spectrometric measurement of the endogenous cannabinoid 2-arachidonylglycerol in the spinal cord and peripheral nervous system. |
1999 |
Zhongguo Yao Li Xue Bao |
pmid:11189199
|
Maccarrone M et al. |
Gas chromatography-mass spectrometry analysis of endogenous cannabinoids in healthy and tumoral human brain and human cells in culture. |
2001 |
J. Neurochem. |
pmid:11208922
|
Kagota S et al. |
2-Arachidonoylglycerol, a candidate of endothelium-derived hyperpolarizing factor. |
2001 |
Eur. J. Pharmacol. |
pmid:11275004
|
Bisogno T et al. |
The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. |
2001 |
Eur. J. Biochem. |
pmid:11277920
|
Wilson RI and Nicoll RA |
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. |
2001 |
Nature |
pmid:11279497
|
Di Marzo V et al. |
Leptin-regulated endocannabinoids are involved in maintaining food intake. |
2001 |
Nature |
pmid:11298451
|
Kobayashi Y et al. |
Activation by 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, of p42/44 mitogen-activated protein kinase in HL-60 cells. |
2001 |
J. Biochem. |
pmid:11328586
|
Kozak KR et al. |
Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid 2-arachidonylglycerol. |
2001 |
J. Biol. Chem. |
pmid:11402053
|
Giuffrida A et al. |
Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. |
2001 |
J. Pharmacol. Exp. Ther. |
pmid:11408519
|
Wang Y et al. |
Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock. |
2001 |
Anal. Biochem. |
pmid:11412008
|
Suhara Y et al. |
Synthesis and biological activities of novel structural analogues of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. |
2001 |
Bioorg. Med. Chem. Lett. |
pmid:11454463
|
Maccarrone M et al. |
Anandamide degradation and N-acylethanolamines level in wild-type and CB1 cannabinoid receptor knockout mice of different ages. |
2001 |
J. Neurochem. |
pmid:11461969
|
Yamaguchi T et al. |
Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice. |
2001 |
Brain Res. |
pmid:11478928
|
Di Marzo V et al. |
Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells. |
2001 |
Biochem. J. |
pmid:11485574
|
Stella N and Piomelli D |
Receptor-dependent formation of endogenous cannabinoids in cortical neurons. |
2001 |
Eur. J. Pharmacol. |
pmid:11513837
|
Hansen HH et al. |
Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. |
2001 |
J. Neurochem. |
pmid:11579150
|
Fowler CJ et al. |
Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide. |
2001 |
Biochem. Pharmacol. |
pmid:11585048
|
Panikashvili D et al. |
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. |
2001 |
Nature |
pmid:11586361
|
Savinainen JR et al. |
Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes. |
2001 |
Br. J. Pharmacol. |
pmid:11588122
|
Berdyshev EV et al. |
Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. |
2001 |
FASEB J. |
pmid:11641243
|
Kurihara J et al. |
2-Arachidonoylglycerol and anandamide oppositely modulate norepinephrine release from the rat heart sympathetic nerves. |
2001 |
Jpn. J. Pharmacol. |
pmid:11676206
|
van der Stelt M et al. |
Exogenous anandamide protects rat brain against acute neuronal injury in vivo. |
2001 |
J. Neurosci. |
pmid:11698588
|
Wagner JA et al. |
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. |
2001 |
J. Am. Coll. Cardiol. |
pmid:11738314
|
Al-Hayani A et al. |
The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. |
2001 |
Neuropharmacology |
pmid:11747904
|
Darmani NA |
The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids. |
2002 |
J. Pharmacol. Exp. Ther. |
pmid:11752094
|
Mechoulam R et al. |
Cannabinoids and brain injury: therapeutic implications. |
2002 |
Trends Mol Med |
pmid:11815270
|
Jordà MA et al. |
Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol. |
2002 |
Blood |
pmid:11929767
|
Sugiura T and Waku K |
2-arachidonoylglycerol: an endogenous cannabinoid receptor agonist. |
2001 |
World Rev Nutr Diet |
pmid:11935957
|
Bisogno T et al. |
Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications. |
2002 |
Curr. Pharm. Des. |
pmid:11945157
|
Kozak KR et al. |
15-Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonist. |
2002 |
J. Biol. Chem. |
pmid:11956198
|
Romero J et al. |
Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study. |
2002 |
Brain Res. Mol. Brain Res. |
pmid:12008024
|
Vannacci A et al. |
Down-regulation by cannabinoids of the immunological activation of human basophils and guinea pig mast cells. |
2002 |
Inflamm. Res. |
pmid:12013387
|
Kreitzer AC and Regehr WG |
Retrograde signaling by endocannabinoids. |
2002 |
Curr. Opin. Neurobiol. |
pmid:12049940
|
Nakane S et al. |
2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain. |
2002 |
Arch. Biochem. Biophys. |
pmid:12051682
|
Sugiura T et al. |
Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052034
|
Fowler CJ and Jacobsson SO |
Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide--targets for drug development? |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052035
|
Högestätt ED and Zygmunt PM |
Cardiovascular pharmacology of anandamide. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052048
|
Kirkham TC et al. |
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. |
2002 |
Br. J. Pharmacol. |
pmid:12055133
|
Kojima S et al. |
Contractile response to a cannabimimetic eicosanoid, 2-arachidonoylglycerol, of longitudinal smooth muscle from the guinea-pig distal colon in vitro. |
2002 |
Eur. J. Pharmacol. |
pmid:12063081
|
Lichtman AH et al. |
Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo. |
2002 |
J. Pharmacol. Exp. Ther. |
pmid:12065702
|
Sugiura T and Waku K |
Cannabinoid receptors and their endogenous ligands. |
2002 |
J. Biochem. |
pmid:12097154
|
Dinh TP et al. |
Brain monoglyceride lipase participating in endocannabinoid inactivation. |
2002 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:12136125
|
Matias I et al. |
Presence and regulation of the endocannabinoid system in human dendritic cells. |
2002 |
Eur. J. Biochem. |
pmid:12153574
|
van der Stelt M et al. |
Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase. |
2002 |
J. Med. Chem. |
pmid:12166944
|
Gubellini P et al. |
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. |
2002 |
J. Neurosci. |
pmid:12177188
|
Kozak KR et al. |
Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. |
2002 |
J. Biol. Chem. |
pmid:12244105
|
Rouzer CA et al. |
Chemical stability of 2-arachidonylglycerol under biological conditions. |
2002 |
Chem. Phys. Lipids |
pmid:12270674
|
Laine K et al. |
Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid. |
2002 |
Invest. Ophthalmol. Vis. Sci. |
pmid:12356827
|
González S et al. |
Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. |
2002 |
Brain Res. |
pmid:12393235
|
Jordà MA et al. |
The peripheral cannabinoid receptor Cb2, a novel oncoprotein, induces a reversible block in neutrophilic differentiation. |
2003 |
Blood |
pmid:12406867
|
van der Stelt M et al. |
Acute neuronal injury, excitotoxicity, and the endocannabinoid system. |
2002 Oct-Dec |
Mol. Neurobiol. |
pmid:12428763
|